Keyphrases
Antagonism
20%
Drug Target
20%
Middle Cerebral Artery
20%
Migraine
100%
Migraine Attack
20%
Migraine Pathophysiology
40%
Migraine Treatment
20%
Migraine without Aura (MWoA)
20%
PAC1 Receptor
40%
Peptide Drugs
100%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
100%
Randomized Clinical Trial
20%
Selective Affinity
20%
Signaling Molecules
20%
Sustained Effect
20%
Vasodilator
20%
Medicine and Dentistry
Middle Cerebral Artery
20%
Migraine
100%
Migraine Treatment
20%
Migraine without Aura
20%
Pathophysiology
40%
Pituitary Adenylate Cyclase-Activating Polypeptide
100%
Randomized Clinical Trial
20%
Receptor
80%
Signaling Molecule
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adenylate Cyclase
100%
Migraine
100%
Migraine without Aura
16%
Pathophysiology
33%
Randomized Clinical Trial
16%
Receptor
66%
Neuroscience
Adenylyl Cyclase
100%
Auras
14%
Middle Cerebral Artery
14%
Migraine
100%
Receptor
57%
Vasodilators
14%